IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 11

Issue Published : 117

Article Submitted : 21307

Article Published : 8476

Total Authors : 22301

Total Reviewer : 802

Total Countries : 156

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Systemic Lupus Erythematosus - A Review
Authors Name: Hari Sudhan.S , Gowtham.V , Hrithish.C , Dr.Ilayanila.C , Dr.Sathish kumar
Download E-Certificate: Download
Author Reg. ID:
IJRTI_185530
Published Paper Id: IJRTI2305020
Published In: Volume 8 Issue 5, May-2023
DOI:
Abstract: Systemic lupus erythematosus (SLE) is an autoimmune disease. It is distinguished by the presence of autoantibodies that are directed against nuclear antigens. Because it affects multiple systems, patients might appear in a wide variety of ways. The complicated aetiopathogenesis of this illness is reflected in the clinical variability of the condition, which emphasises the significance of genetic determinants and individual vulnerability to environmental influences. Every organ in the body is susceptible to SLE. Rash, arthritis, and exhaustion are the most typical symptoms. SLE can induce nephritis, neurological issues, anaemia, and thrombocytopenia at the more severe end of the spectrum. Substantial titres are acknowledged to be of 1:80 or greater. Relapsing and remitting SLE has three therapeutic goals: managing acute episodes of potentially fatal illness, reducing the likelihood of flares during times of relative stability, and managing the less serious but frequently incapacitating day-to-day symptoms. Corticosteroids and immunosuppressive therapies are typically reserved for major organ involvement; anti-CD20 monoclonal antibody is now used in patients with severe disease who have not responded to conventional treatments. Despite major advancements in prognosis brought about by the use of corticosteroids and immunosuppressive medications, SLE still has a sizable effect on the mortality and morbidity of people affected.
Keywords: Systemic lupus erythematosus, lupus.
Cite Article: "Systemic Lupus Erythematosus - A Review ", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 5, page no.144 - 146, May-2023, Available :http://www.ijrti.org/papers/IJRTI2305020.pdf
Downloads: 000205184
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2305020
Registration ID:185530
Published In: Volume 8 Issue 5, May-2023
DOI (Digital Object Identifier):
Page No: 144 - 146
Country: Chengalpet dt, Tamil Nadu , India
Research Area: Medical Science
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2305020
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2305020
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner